Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SFA_DIH_nad_40%_espi.pdfNotification for share participation from “Donev investments holding” AD

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 42 / 2024
Date of issue: 2024-06-14
Short name of the issuer
SOPHARMA AD
Subject
Notification for share participation from “Donev investments holding” AD
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, June 14, 2024 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD (SFA: “BSE” AD, SPH: Warsaw Stock Exchange) notifies that the Company received a notification of shareholding from "Donev investments holding" AD, UIC 831915121, from which it is clear that with a share transaction with settlement on June 14, 2024 "Donev investments holding" AD increases its direct participation in the capital of the Company to 40.05% crossing the threshold of 40%.
Annexes
File Description
SFA_DIH_nad_40%_espi.pdf
SFA_DIH_nad_40%_espi.pdf		 Notification for share participation from “Donev investments holding” AD

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-06-14 Ognian Donev Executive director